John Gross, PhD
HIV-1, HIV-2, cellular restriction factors and viral antagonists, genetic conflicts, viral evolution, structural biology, drug discovery
HIV-1, HIV-2, cellular restriction factors and viral antagonists, genetic conflicts, viral evolution, structural biology, drug discovery
HIV cure, HIV immunotherapy, CD8+ T cell biology, Vaccines
HIV cure, HIV clinical trials, Clinical Research, Translational research, COVID-19, Post-acute sequelae of COVID-19 (PASC), Long COVID, Viral persistence
Viral Persistence, HIV-1, SARS-CoV-2, Human Herpes Viruses, Viral Reservoirs, HIV Cure, Translational Virology, Infectious Diseases, Viral-Host Interactions, Single-Cell Analysis, Post-Acute Sequelae, Molecular Imaging, PET imaging, Infectious Disease Molecular Imaging, Digital Spatial Analyses
Prevention, epidemiology, testing, treatment policy, combination prevention, implementation science, surveillance, tuberculosis co-infection
HIV Evolution, Pathogenesis, Persistence, Cell-Intrinsic Immunity, Interferon-alpha, Viral Disease Biomarkers, Cell-free DNA
Antigens, Bacteria; Interferon-gamma, Tuberculosis, Mycobacterium TB, Pulmonary TB
HIV-1 cure, latency, and viral reservoirs; HIV transcription and epigenetic regulation; CRISPR/Cas diagnostics; human organoids (airway, gut, brain) and animal models for viral diseases; SARS-CoV-2 and post-acute COVID / long COVID; virus–host protein interaction networks; bunyaviruses
HIV persistence, Immunity, T cells, single-cell "omics", COVID-19, Women's Health, Mucosa